HTL0030310

· Nxera Pharma UK Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HTL0030310, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310 [Phase 1]